SCHEMBL6597498

SCHEMBL6597498

CCOc1ccc(CC(=O)Cl)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.54
SMN1; SMN2 Q16637 5/20 0.50
LMNA P02545 3/20 0.50
CSNK2A1 P68400 2/20 0.46
ATM Q13315 2/20 0.46
MEN1 O00255 1/20 0.46
POLB P06746 1/20 0.46
GAA P10253 1/20 0.46
KMT2A Q03164 1/20 0.46
MCL1 Q07820 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAPT P10636 4/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 2/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP2C9 P11712 1/20 0.45
RAB9A P51151 5/20 0.44
NPC1 O15118 4/20 0.44
HPGD P15428 2/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10899796 0.87 CA2 (0.56) RORCSMN1; SMN2LMNAMEN1POLB
SCHEMBL2394373 0.87 ALDH1A1 (0.57) SMN1; SMN2LMNAMEN1POLBGAA
SCHEMBL9309743 0.84 ATM (0.56) SMN1; SMN2CSNK2A1ATMMEN1KMT2A
SCHEMBL3616256 0.83 ALDH1A1 (0.53) SMN1; SMN2LMNAMEN1GAAKMT2A
SCHEMBL11013101 0.80 GAA (0.50) SMN1; SMN2ATMGAATDP1MAPT
SCHEMBL3718539 0.80 RAB9A (0.56) RORCSMN1; SMN2LMNACSNK2A1ATM
SCHEMBL11013100 0.80 CSNK2A1 (0.51) RORCSMN1; SMN2LMNACSNK2A1ATM
SCHEMBL11265562 0.79 ALDH1A1 (0.44) SMN1; SMN2LMNAPOLBMAPTCYP1A2
SCHEMBL12503974 0.79 CSNK2A1 (0.54) RORCSMN1; SMN2LMNACSNK2A1ATM
SCHEMBL6597514 0.78 LMNA (0.57) SMN1; SMN2LMNAMEN1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1280802-B1 INDAZOLES SUBSTITUTED WITH 1,1-DIOXOISOTHIAZOLIDINE USEFUL AS INHIBITORS OF CELL PROLIFERATION LG LIFE SCIENCES LTD (KR) 2004-05-06 EP disclosed
US-6620831-B2 Cyclin dependent kinase inhibitors; anticarcinogenic and antiinflammatory agents; restenosis, angiogenesis LG LIFE SCIENCES LTD. (KR) 2003-09-16 US disclosed
US-20030149034-A1 INDAZOLES SUBSTITUTED WITH1,1-DIOXOISOTHIAZOLIDINE USEFUL AS INHIBITORS OF CELL PROLIFERATION LG LIFE SCIENCES LTD. (KR) 2003-08-07 US disclosed
EP-1280802-A4 INDAZOLES SUBSTITUTED WITH 1,1-DIOXOISOTHIAZOLIDINE USEFUL AS INHIBITORS OF CELL PROLIFERATION LG LIFE SCIENCES LTD (KR) 2003-06-11 EP disclosed
EP-1280802-A1 INDAZOLES SUBSTITUTED WITH 1,1-DIOXOISOTHIAZOLIDINE USEFUL AS INHIBITORS OF CELL PROLIFERATION LG Life Sciences Ltd. (KR) 2003-02-05 EP disclosed
WO-2001085726-A1 INDAZOLES SUBSTITUTED WITH 1,1-DIOXOISOTHIAZOLIDINE USEFUL AS INHIBITORS OF CELL PROLIFERATION LG LIFE SCIENCES LTD. (KR) 2001-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149034-A1 INDAZOLES SUBSTITUTED WITH1,1-DIOXOISOTHIAZOLIDINE USEFUL AS INHIBITORS OF CELL PROLIFERATION CCNA1, CCNI, CCNT1 RORC 960/4885SMN1; SMN2 4291/4885LMNA 4245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.